Basit öğe kaydını göster

dc.contributor.authorCengiz, K
dc.contributor.authorGunaydin, M
dc.contributor.authorBedir, A
dc.contributor.authorPekbay, A
dc.date.accessioned2020-06-21T15:53:04Z
dc.date.available2020-06-21T15:53:04Z
dc.date.issued1998
dc.identifier.issn0028-2766
dc.identifier.urihttps://doi.org/10.1159/000045095
dc.identifier.urihttps://hdl.handle.net/20.500.12712/22538
dc.descriptionWOS: 000075230300013en_US
dc.descriptionPubMed: 9689165en_US
dc.description.abstractA possible agent for human non-A-E hepatitis has been identified and named hepatitis G virus (HGV). HGV is also a flavivirus, and the clinical characteristics and risk factors of HGV infection may be similar to those of hepatitis C virus infection. Hepatitis C virus infection may manifest as a primary glomerulonephritis. The aim of this study is to evaluate the prevalence of serum HGV RNA in 98 adult patients with biopsy-proven glomerular diseases. We found that only 3 patients (3%) out of 98 with primary glomerulonephritis had HGV RNA. One of 59 (1.7%) healthy controls was serum HGV RNA positive (p > 0.05). The prevalence of serum HGV RNA was low in the patients with primary glomerulonephritis.en_US
dc.language.isoengen_US
dc.publisherKargeren_US
dc.relation.isversionof10.1159/000045095en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjecthepatitis G virusen_US
dc.subjectglomerular diseasesen_US
dc.titleLow prevalence of hepatitis G virus antibodies in glomerular diseasesen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume79en_US
dc.identifier.issue4en_US
dc.identifier.startpage472en_US
dc.identifier.endpage473en_US
dc.relation.journalNephronen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster